[1] Olivas I, Rodriguez-Tajes S, Londono MC. Autoimmune hepatitis: challenges and novelties. Med Clin (Barc), 2022,159(6):289-298. [2] Sarcognato S, Sacchi D, Grillo F,et al. Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis. Pathologica, 2021,113(3):170-184. [3] 张明月,赵军,谢欢,等.原发性胆汁性胆管炎免疫发病机制.中华肝脏病杂志, 2021, 29(6):500-504. [4] Fan J, Jiang T, He D. Genetic link between rheumatoid arthritis and autoimmune liver diseases: A two-sample Mendelian randomization study. Semin Arthr Rheum, 2023,5(8):152-153. [5] Blombery P, Pazhakh V, Albuquerque AS,et al. Biallelic deleterious germline SH2B3 variants cause a novel syndrome of myeloproliferation and multi-organ autoimmunity. EJHaem, 2023,4(2):463-469. [6] Wang LN, Zhang ZT, Wang L,et al. TGF-β1/SH2B3 axis regulates anoikis resistance and EMT of lung cancer cells by modulating JAK2/STAT3 and SHP2/Grb2 signaling pathways. Cell Death Dis, 2022,13(5):472-473. [7] Engel B, Laschtowitz A, Janik MK,et al. Genetic aspects of adult and pediatric autoimmune hepatitis: A concise review. Eur J Med Genet, 2021,64(6):1042-1044. [8] 中华医学会风湿病分会.自身免疫性肝病诊断和治疗指南.中华风湿病学杂志, 2011, 15(8):556-558. [9] 冯静,罗思剑,李靖,等.不同类型自身免疫性肝病患者肝组织炎症因子表达的变化.实用肝脏病杂志, 2020, 23(3):356-359. [10] 中国医师协会风湿免疫科医师分会自身抗体检测专业委员会,国家风湿病数据中心,国家皮肤与免疫疾病临床医学研究中心.自身免疫性肝病相关自身抗体检测的临床应用专家共识.中华内科杂志, 2021, 60(7):619-625. [11] 束庆,刘蕴星,葛泳含,等.ABCB1 2677G>T/A基因多态性与自身免疫病患者环孢素A血药浓度个体差异的相关性研究.中华风湿病学杂志, 2021, 25(7):433-440. [12] Vandewalle J, Desouter AK, Van der Auwera BJ,et al. CTLA4, SH2B3, and CLEC16A diversely affect the progression of early islet autoimmunity in relatives of Type 1 diabetes patients. Clin Exp Immunol, 2023,211(3):224-232. [13] 冯宇,杜振元,李艳彬,等.酒精性肝病患者血清IL-17水平及其基因-197A/G位点单核苷酸多态性分析.实用肝脏病杂志, 2022,25(1):58-61. [14] Vermeersch G, Devos T, Devos H, et al. Germline heterozygous SH2B3-mutations and (idiopathic) erythrocytosis: Detection of a previously undescribed mutation. EJHaem, 2023,4(4):1143-1147. [15] Zhang Y, Morris R, Brown GJ, et al. Rare SH2B3 coding variants in lupus patients impair B cell tolerance and predispose to autoimmunity. J Exp Med, 2024,221(4):202-204. [16] Baccelli F, Leardini D, Muratore E, et al. Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants. Hum Genomics, 2022,16(1):40-42. [17] Bastidas Torres AN, Cats D. Deregulation of JAK2 signaling underlies primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma. Haematologica, 2022,107(3):702-714. [18] 符馨尹,林小茹,郑秀芬,等.药物诱导性自身免疫性肝炎与药物性肝损伤和自身免疫性肝炎患者临床特征比较.实用肝脏病杂志, 2023,26(4):512-515. [19] Schattenberg JM, Pares A, Kowdley KV, et al. A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA. J Hepatol,2021,74(6):1344-1354. [20] Harrington C, Krishnan S, Mack CL, et al. Noninvasive biomarkers for the diagnosis and management of autoimmune hepatitis. Hepatology, 2022,76(6):1862-1879. |